Impact of Periodontal Therapy on Patients With Diabetes

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 116 participants.

Also called NCT04830969

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 116 participants (enrolled count) (from the registry)
Sponsor
State University of New York at Buffalo (from the registry)
Registry
  • NCT NCT04830969
Other papers using this trial's data
  • Randomized Trial to Test a Chemo-Mechanical Antiplaque Regimen as Adjunct to Periodontal Therapy JDR clinical and translational research, 2024-04 DOI, PubMed 37148266

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04830969. Randomized; triple masking; primary purpose treatment. Start 2016-11-08 (actual); primary completion 2021-01-28 (actual). Results posted on 2023-03-01.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Impact of Periodontal Therapy on Patients With Diabetes
Acronym
DMRCT
Condition
Diabetes Mellitus, Type II
Condition
Periodontitis
Intervention (Drug)
Chlorhexidine gluconate oral rinse
Intervention (Procedure)
Scaling & Root Planing
Intervention (Device)
Soft Picks
Lead sponsor
State University of New York at Buffalo (class: other)
Collaborator
Sunstar, Inc. (class: industry)

Record details

Record id
cardio:ct-nct04830969
Content hash
da189304b31beb0ae2b67cccaa39c4e6d9315208991ba7a5b4646763369fc693